Literature DB >> 8274184

The kindling hypothesis: further evidence from a U.S. national study of alcoholic men.

B M Booth1, F C Blow.   

Abstract

A sample of 6818 alcoholic men participating in a short in-patient detoxification episode was studied to examine the kindling effect of repeated prior alcohol withdrawals on occurrence of seizures or severe withdrawal problems observed during the hospitalization. Subjects studied were hospitalized in one of 172 U.S. Department of Veterans Affairs medical centers. Patients with seizures and withdrawal problems had more prior detoxifications and other alcohol-specific hospitalizations. They were also more likely to be later readmitted for an alcoholism diagnosis. Patients with withdrawal problems during the detoxification episode studied were more likely to have such problems again as well as seizures during the readmission; those with seizures during the index detoxification were more likely to have repeated seizures during the readmission. These results confirm the kindling effect in a large, multi-site patient sample and suggest that alcohol detoxification programs may need to consider anticonvulsant therapy in patients with many prior detoxifications or withdrawals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8274184

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  35 in total

Review 1.  Functional genomics strategies to identify susceptibility genes and treatment targets in alcohol dependence.

Authors:  Markus Heilig; Wolfgang Sommer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

Review 3.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Plasticity of GABAA receptors in brains of rats treated with chronic intermittent ethanol.

Authors:  Richard W Olsen; Jing Liang; Elisabetta Cagetti; Igor Spigelman
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 5.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.

Authors:  Zhongqi Zhang; Andrew C Morse; George F Koob; Gery Schulteis
Journal:  Alcohol Clin Exp Res       Date:  2007-09-14       Impact factor: 3.455

7.  Multi-modal imaging reveals differential brain volumetric, biochemical, and white matter fiber responsivity to repeated intermittent ethanol vapor exposure in male and female rats.

Authors:  Natalie M Zahr; Aran M Lenart; Joshua A Karpf; Keriann M Casey; Kilian M Pohl; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropharmacology       Date:  2020-03-30       Impact factor: 5.250

8.  Severity of alcohol withdrawal symptoms depends on developmental stage of Long-Evans rats.

Authors:  Chun-Shiang Chung; Jian Wang; Monh Wehman; Dennis E Rhoads
Journal:  Pharmacol Biochem Behav       Date:  2007-12-08       Impact factor: 3.533

9.  Transient CNS responses to repeated binge ethanol treatment.

Authors:  Natalie M Zahr; Torsten Rohlfing; Dirk Mayer; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Addict Biol       Date:  2015-08-18       Impact factor: 4.280

10.  Preventive effects of Flos Perariae (Gehua) water extract and its active ingredient puerarin in rodent alcoholism models.

Authors:  Zaijun Zhang; Sha Li; Jie Jiang; Pei Yu; Jing Liang; Yuqiang Wang
Journal:  Chin Med       Date:  2010-10-26       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.